Key result
Combined L5 + V5 plasma concentration correlated with age-adjusted 10-year hard CHD risk and was higher in high vs. low CHD risk individuals.
Why the study?
The most electronegative constituents of human plasma LDL (L5) and VLDL (V5) are highly atherogenic, but whether their combined electronegativity (L5 + V5) plays a role in coronary heart disease was uncertain.
Does combined plasma LDL and VLDL electronegativity (L5 + V5) correlate with 10-year hard coronary heart disease risk in asymptomatic individuals and induce vascular endothelial senescence?
Cross-Sectional (n=33)
Yes
Does combined plasma LDL and VLDL electronegativity (L5 + V5) correlate with 10-year hard coronary heart disease risk in asymptomatic individuals and induce vascular endothelial senescence?
Answers are grounded in this paper and cite their sources.
Combined plasma concentrations of electronegative LDL and VLDL (L5 + V5) correlate with estimated 10-year hard CHD risk in asymptomatic adults and promote vascular endothelial senescence in experimental models.
The most electronegative constituents of human plasma LDL (i.e., L5) and VLDL (i.e., V5) are highly atherogenic. We determined whether the combined electronegativity of L5 and V5 (i.e., L5 + V5) plays a role in coronary heart disease (CHD). In 33 asymptomatic individuals (ages 32–64), 10-year hard CHD risk correlated with age (r = 0.42, p = 0.01). However, in age-adjusted analyses, 10-year hard CHD risk correlated with L5 + V5 plasma concentration (r = 0.43, p = 0.01) but not age (p = 0.74). L5 + V5 plasma concentration was significantly greater in the group with high CHD risk (39.4 ± 22.0 mg/dL; n = 17) than in the group with low CHD risk (16.9 ± 14.8 mg/dL; n = 16; p = 0.01). In cultured human aortic endothelial cells, L5 + V5 treatment induced significantly more senescence-associated–β-Gal activity than did equal concentrations of L1 + V1 (n = 4, p < 0.001). To evaluate the in vivo relevance of these findings, we fed ApoE−/− and wild-type mice with a high-fat diet and found that plasma LDL, VLDL, and LDL + VLDL from ApoE−/− mice exhibited significantly greater electrophoretic mobility than did wild-type counterparts (n = 6, p < 0.01). The increased electronegativity of LDL and VLDL in ApoE−/− mice was accompanied by increased aortic lipid accumulation and cellular senescence (n = 6, p < 0.05). Clinical trials are warranted to test the predictive value of L5 + V5 concentration in patients with CHD.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2019) conducted a cross-sectional in Asymptomatic individuals without coronary heart disease (n=33). Combined electronegative LDL and VLDL (L5 + V5) plasma concentration vs. Low CHD risk group / lower L5 + V5 levels (and L1 + V1 in vitro; wild-type mice in vivo) was evaluated on Age-adjusted 10-year hard coronary heart disease (CHD) risk (Framingham risk score) and L5 + V5 plasma concentration by CHD risk group (r = 0.43, p=0.01). Combined L5 + V5 plasma concentration correlated with age-adjusted 10-year hard CHD risk and was higher in high vs. low CHD risk individuals.
Synapse has enriched 10 related papers. Consider them for comparative context: